Thomas Ernst

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Thomas Ernst, Andrew Chase, Joannah Score et al. · Nature Genetics · 2010 · 1.1K citations

Life Sciences, Genetics, Molecular Biology +14

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Evidence for long-term neurotoxicity associated with methamphetamine abuse

Thomas Ernst, Linda Chang, Maria Leonido–Yee et al. · Neurology · 2000 · 376 citations

Pharmacy, Neuroscience, Toxicology +17

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study

Eva Kirmeier, Lars I. Eriksson, Heidrun Lewald et al. · The Lancet Respiratory Medicine · 2018 · 374 citations · Full text

Medicine, Anesthesiology, Perioperative Medicine +13

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms

Francis Grand, Claire Hidalgo-Curtis, Thomas Ernst et al. · Blood · 2009 · 370 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12